Kajanoja P, Jungner G, Seppälä M, Karjalainen O, Widholm O
Acta Obstet Gynecol Scand Suppl. 1974;37:51-6. doi: 10.3109/00016347409156414.
In the first part of the survey 424 midtrimester abortion inductions with 11 different regimes of treatment were analyzed according to PG dose, PG type (PGF2alpha or PGE2), the route of administration (intravenous, extra-amniotic, and intra-amniotic), and the dose of concomitant intravenous oxytocin. Intraamniotic PG was given as a single injection, and the dose was repeated after 24 hours, if the abortion was not imminent. The highest efficacy, a 90% success rate within 24 hours and a 100% rate in 48 hours, as well as the shortest induction-abortion interval were achieved with the intra-amniotic administration of 50 mg of PGF2alpha either alone or with supplementary oxytocin, or with the intra-amniotic 10 mg PGE2 plus oxytocin.
在调查的第一部分,根据前列腺素(PG)剂量、PG类型(PGF2α或PGE2)、给药途径(静脉内、羊膜外和羊膜内)以及静脉内催产素的剂量,对采用11种不同治疗方案进行的424例孕中期引产进行了分析。羊膜内PG采用单次注射给药,如果流产未即刻发生,则在24小时后重复给药剂量。单独羊膜内注射50mg PGF2α或联合补充催产素,或羊膜内注射10mg PGE2加催产素,均能达到最高疗效,即24小时内成功率达90%,48小时内达100%,且引产-流产间隔最短。